Xolair 150 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB25FUJQZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,122
Award facts
- Contract value 100% obligated
- $17,122.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $17,122.20 by the Defense Logistics Agency on August 1, 2025, for the supply of Xolair 150 mg/ml auto-injectors. The award is issued under a firm fixed-price contract structure with an ultimate completion date of August 22, 2025, and represents no set-aside designation. This delivery order draws from DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products for military healthcare facilities worldwide.
Xolair (omalizumab) is a biologic medication used primarily for severe asthma and chronic urticaria treatment. As a supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group fulfills critical medication distribution needs to Department of Defense healthcare sites. The company's established portfolio with the DLA encompasses an extensive range of pharmaceutical products including prescription medications, biologics, vaccines, and specialty medical consumables, positioning it as a vital vendor for military health system support operations.
Quick answers
Who was awarded contract SPE2DB25FUJQZ?
SPE2DB25FUJQZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DB25FUJQZ worth?
The government has obligated $17,122 on SPE2DB25FUJQZ.
Is contract SPE2DB25FUJQZ an order under another contract?
Yes. SPE2DB25FUJQZ is a delivery order under SPE2DB25D9365, an indefinite delivery contract.
Was contract SPE2DB25FUJQZ competed?
The extent of competition for SPE2DB25FUJQZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award